We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Formation of Prostate Cancer Precursor Blocked by "Longevity" Gene

By LabMedica International staff writers
Posted on 30 Jan 2011
Mice genetically engineered to lack the "longevity" gene SIRT1 demonstrated decreased levels of cellular autophagy, which resulted in the formation of precancerous lesions known as prostatic intraepithelial neoplasia (PIN). More...
SIRT1 is an enzyme that deacetylates proteins that contribute to cellular regulation (reaction to stressors, longevity).

Autophagy is required for the degradation of damaged organelles and long-lived proteins, as well as for the development of glands such as the breast and prostate. To probe the relationship between autophagy and PIN development investigators at Thomas Jefferson University (Philadelphia, PA, USA) expanded upon previous tissue culture studies on SIRT1 by genetically engineering lines of mice either to lack or to overexpress the gene.

They reported in the December 28, 2010, online edition of the journal Cancer Research that homozygous deletion of the SIRT1 gene in mice resulted in development of PIN associated with reduced autophagy. Genome-wide gene expression analysis of prostates from mice lacking Sirt1 demonstrated that endogenous SIRT1 repressed androgen responsive gene expression and induced autophagy in the prostate.

"Prostate cancer is one of the malignancies that has a very direct relationship to aging," said senior author Dr. Richard G. Pestell, professor of cancer biology at Thomas Jefferson University. "And these results provide a direct link for the first time between the onset of prostate cancer and the SIRT1 gene that regulate aging. If you inactivate this gene, then you get the prostate cancer precursor, known as PIN. So it tells you that this "longevity" gene is normally blocking prostate cancer."

Related Links:
Thomas Jefferson University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.